Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, Nikos Papakonstantinou, Maurilio Ponzoni, Charles C. Chu, Davide Rossi, Gianluca Gaidano, Nicholas Chiorazzi, Kostas Stamatopoulos, Paolo Ghia

Research output: Contribution to journalArticle

Abstract

Subset #8 is a distinctive subset of patients with chronic lymphocytic leukemia (CLL) defined by the expression of stereotyped IGHV4-39/IGKV1(D)-39 B-cell receptors. Subset #8 patients experience aggressive disease and exhibit the highest risk for Richter transformation among all CLL. In order to obtain biological insight into this behavior, we profiled the antigen reactivity and signaling capacity of subset #8 vs other clinically aggressive stereotyped subsets, namely subsets #1 and #2. Twenty-seven monoclonal antibodies (mAbs) from subsets #1, #2, and #8 CLL clones were prepared as recombinant human immunoglobulin G1 and used as primary antibodies in enzyme-linked immunosorbent assays against representatives of the major classes of established antigenic targets for CLL. Subset #8 CLL mAbs exhibited broad polyreactivity as they bound to all antigens tested, in clear contrast with the mAbs from the other subsets. Antigen challenge of primary CLL cells indicated that the promiscuous antigen-binding activity of subset #8 mAbs could lead to significant cell activation, again in contrast to the less responsive CLL cells from subsets #1 and #2. These features constitute a distinctive profile for CLL subset #8, supporting the existence of distinct mechanisms of aggressiveness in different immunogenetic subsets of CLL.

Original languageEnglish
Pages (from-to)3580-3587
Number of pages8
JournalBlood
Volume125
Issue number23
DOIs
Publication statusPublished - Jun 4 2015

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Monoclonal Antibodies
Antigens
Immunosorbents
Immunoglobulins
Assays
Chemical activation
Cells
Antibodies
Immunogenetics
Enzymes
B-Lymphocytes
Clone Cells
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8. / Gounari, Maria; Ntoufa, Stavroula; Apollonio, Benedetta; Papakonstantinou, Nikos; Ponzoni, Maurilio; Chu, Charles C.; Rossi, Davide; Gaidano, Gianluca; Chiorazzi, Nicholas; Stamatopoulos, Kostas; Ghia, Paolo.

In: Blood, Vol. 125, No. 23, 04.06.2015, p. 3580-3587.

Research output: Contribution to journalArticle

Gounari, M, Ntoufa, S, Apollonio, B, Papakonstantinou, N, Ponzoni, M, Chu, CC, Rossi, D, Gaidano, G, Chiorazzi, N, Stamatopoulos, K & Ghia, P 2015, 'Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8', Blood, vol. 125, no. 23, pp. 3580-3587. https://doi.org/10.1182/blood-2014-09-603217
Gounari, Maria ; Ntoufa, Stavroula ; Apollonio, Benedetta ; Papakonstantinou, Nikos ; Ponzoni, Maurilio ; Chu, Charles C. ; Rossi, Davide ; Gaidano, Gianluca ; Chiorazzi, Nicholas ; Stamatopoulos, Kostas ; Ghia, Paolo. / Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8. In: Blood. 2015 ; Vol. 125, No. 23. pp. 3580-3587.
@article{e20e6e4f5d9840af9990cb0790683704,
title = "Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8",
abstract = "Subset #8 is a distinctive subset of patients with chronic lymphocytic leukemia (CLL) defined by the expression of stereotyped IGHV4-39/IGKV1(D)-39 B-cell receptors. Subset #8 patients experience aggressive disease and exhibit the highest risk for Richter transformation among all CLL. In order to obtain biological insight into this behavior, we profiled the antigen reactivity and signaling capacity of subset #8 vs other clinically aggressive stereotyped subsets, namely subsets #1 and #2. Twenty-seven monoclonal antibodies (mAbs) from subsets #1, #2, and #8 CLL clones were prepared as recombinant human immunoglobulin G1 and used as primary antibodies in enzyme-linked immunosorbent assays against representatives of the major classes of established antigenic targets for CLL. Subset #8 CLL mAbs exhibited broad polyreactivity as they bound to all antigens tested, in clear contrast with the mAbs from the other subsets. Antigen challenge of primary CLL cells indicated that the promiscuous antigen-binding activity of subset #8 mAbs could lead to significant cell activation, again in contrast to the less responsive CLL cells from subsets #1 and #2. These features constitute a distinctive profile for CLL subset #8, supporting the existence of distinct mechanisms of aggressiveness in different immunogenetic subsets of CLL.",
author = "Maria Gounari and Stavroula Ntoufa and Benedetta Apollonio and Nikos Papakonstantinou and Maurilio Ponzoni and Chu, {Charles C.} and Davide Rossi and Gianluca Gaidano and Nicholas Chiorazzi and Kostas Stamatopoulos and Paolo Ghia",
year = "2015",
month = "6",
day = "4",
doi = "10.1182/blood-2014-09-603217",
language = "English",
volume = "125",
pages = "3580--3587",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "23",

}

TY - JOUR

T1 - Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

AU - Gounari, Maria

AU - Ntoufa, Stavroula

AU - Apollonio, Benedetta

AU - Papakonstantinou, Nikos

AU - Ponzoni, Maurilio

AU - Chu, Charles C.

AU - Rossi, Davide

AU - Gaidano, Gianluca

AU - Chiorazzi, Nicholas

AU - Stamatopoulos, Kostas

AU - Ghia, Paolo

PY - 2015/6/4

Y1 - 2015/6/4

N2 - Subset #8 is a distinctive subset of patients with chronic lymphocytic leukemia (CLL) defined by the expression of stereotyped IGHV4-39/IGKV1(D)-39 B-cell receptors. Subset #8 patients experience aggressive disease and exhibit the highest risk for Richter transformation among all CLL. In order to obtain biological insight into this behavior, we profiled the antigen reactivity and signaling capacity of subset #8 vs other clinically aggressive stereotyped subsets, namely subsets #1 and #2. Twenty-seven monoclonal antibodies (mAbs) from subsets #1, #2, and #8 CLL clones were prepared as recombinant human immunoglobulin G1 and used as primary antibodies in enzyme-linked immunosorbent assays against representatives of the major classes of established antigenic targets for CLL. Subset #8 CLL mAbs exhibited broad polyreactivity as they bound to all antigens tested, in clear contrast with the mAbs from the other subsets. Antigen challenge of primary CLL cells indicated that the promiscuous antigen-binding activity of subset #8 mAbs could lead to significant cell activation, again in contrast to the less responsive CLL cells from subsets #1 and #2. These features constitute a distinctive profile for CLL subset #8, supporting the existence of distinct mechanisms of aggressiveness in different immunogenetic subsets of CLL.

AB - Subset #8 is a distinctive subset of patients with chronic lymphocytic leukemia (CLL) defined by the expression of stereotyped IGHV4-39/IGKV1(D)-39 B-cell receptors. Subset #8 patients experience aggressive disease and exhibit the highest risk for Richter transformation among all CLL. In order to obtain biological insight into this behavior, we profiled the antigen reactivity and signaling capacity of subset #8 vs other clinically aggressive stereotyped subsets, namely subsets #1 and #2. Twenty-seven monoclonal antibodies (mAbs) from subsets #1, #2, and #8 CLL clones were prepared as recombinant human immunoglobulin G1 and used as primary antibodies in enzyme-linked immunosorbent assays against representatives of the major classes of established antigenic targets for CLL. Subset #8 CLL mAbs exhibited broad polyreactivity as they bound to all antigens tested, in clear contrast with the mAbs from the other subsets. Antigen challenge of primary CLL cells indicated that the promiscuous antigen-binding activity of subset #8 mAbs could lead to significant cell activation, again in contrast to the less responsive CLL cells from subsets #1 and #2. These features constitute a distinctive profile for CLL subset #8, supporting the existence of distinct mechanisms of aggressiveness in different immunogenetic subsets of CLL.

UR - http://www.scopus.com/inward/record.url?scp=84930966113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930966113&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-09-603217

DO - 10.1182/blood-2014-09-603217

M3 - Article

C2 - 25900981

AN - SCOPUS:84930966113

VL - 125

SP - 3580

EP - 3587

JO - Blood

JF - Blood

SN - 0006-4971

IS - 23

ER -